In Depth 30 Dec 2020
A Look Back at the Past Decade of European Biotech
…said Martin Bonde, CEO of Inthera Biosciences in Switzerland. “For instance, we are now much better at treating multiple myeloma and malignant melanoma than we were 10 years ago. At…